Bactericidal activity of gatifloxacin (AM-1155) against Pseudomonas aeruginosa and Enterococcus faecalis in an in vitro bladder model simulating human urinary concentrations after oral administration

Chemotherapy

Volumn 46, Issue 2, 2000, Pages 122-128

  Takahashi, Satoshi ^a   Ebisu, Hiroyuki ^b   Hirose, Takaoki ^a   Sano, Masato ^a   Nishimura, Masahiro ^a   Hirai, Keiji ^b   Tsukamoto, Taiji ^a   Hosaka, Masaki ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bactericidal activity; Bladder model; Gatifloxacin; Urinary tract infections

Indexed keywords

GATIFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BLADDER DISEASE; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIMULATION; URINARY TRACT INFECTION;

EID: 0033973443     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007266     Document Type: Article

References (11)

1. Grasso S, Meinard G, Carneri I, Tamassia V: New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob Agents Chemother 1978;13:570-576.
2. Blaser J, Stone BB, Groner MC, Zinner SH: Comparative study with enoxacin an netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother 1987;31:1054-1060.
3. Zabinski RA, Vance-Bryan K, Krine AJ, Walker KJ, Moody JA, Rotschafer JC: Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. Antimicrob Agents Chemother 1993;37:2454-2458.
4. Hirai K, Yasue T, Hosaka M, Wakabayashi E, Tomizawa H, Nishino K: In vitro antibacterial activity of AM-1155. Drugs 1993:45(suppl 3): 182-183.
5. Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K: In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36:2108-2117.
6. Tomioka H, Saito H, Sato K: Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, spafloxacin, and ofloxacin. Antimicrob Agents Chemother 1993;37:1259-1263.
7. Wakabayashi E, Mitsuhashi S: In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quiolone. Antimicrob Agents Chemother 1994;38:594-601.
8. Nakashima M, Uematu T, Kosuge K, Kusajima H, Ooie T, Masuda Y, Ishada R, Uchida H: Single-and multiple-dose pharmacotkinetics of AM-1155, a new 6-fluoro-8-methoxy quiolone, in humans. Antimicrob Agents Chemother 1995;39: 2635-2640.
9. Nishimura M, Kumamoto Y, Hirose T, Sano M, Ohya S: Study on MIC breakpoint and method of antimicrobial chemotherapy for moderately complicated urinary tract infection - Study using an automatic simulator of urinary antibiotic agent concentration (in Japanese). Kansenshogaku Zasshi 1994;68:366-385.
10. Nishimura M, Kumamoto Y, Shibuya A, Hirose T, Tsukamoto T: An in vitro study on the treatment of complicated cystitis using an automatic simulator (in Japanese). Kansenshogaku Zasshi 1990;64:1004-1012.
11. Takahashi S, Sano S, Nishimura M, Matsukawa M, Mikami M, Hirose T: Bactericidal effect of levofloxacin on strains with equal susceptibility in an in vitro urinary bladder model. Chemotherapy 1998;44:337-342.